InvestorsHub Logo
Followers 25
Posts 5876
Boards Moderated 0
Alias Born 03/15/2014

Re: Adrock post# 28116

Sunday, 11/15/2015 4:06:08 PM

Sunday, November 15, 2015 4:06:08 PM

Post# of 140510
I dont know what to say other than keep trying. What route are you taking? Are you being patched through to Randall's direct line? I cant do anything to get them to answer the phone. I am speaking from my personal experience and Ive been able to get responses from both J. Hargrove (last year) and S. Randall (last week). I was asked not to discuss my conversation online, so Im not going to do it. It's called integrity. Someone on this board has already been black-balled. You can pretty much guess who that was - he admitted his "contact" cut him off months ago. AGAIN, no trade secrets were handed out. I received clarification on certain concerns I have/had. I am still critical about their general IR approach but Im less concerned about the development process. If we get to the end of Q1 2016 without the 5 additional in-human prototypes, I will be more concerned.

I do suggest EVERYONE learn about / research the Engineering Verification Testing (EVT) process so you understand what goes into it. It is impossible to put an exact timeframe on how long this process will take. This is when the engineering prototypes are tweaked and tweaked some more. Often companies will build an EVT prototype, then take the whole thing apart piece by piece. The fact that the timeline for the in-human machines has just been moved to Q1 and they do not expect a delay in human trials is POSITIVE news. I conclude from this that there is not any new, significant re-tooling that needs to occur. Again, this news is all public. So if you have more questions about the process keep calling Titan.